Lycia Therapeutics, Inc. (NASDAQ:LYCA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Aetna Wun Trombley | President and CEO · Since at least Nov 5, 2026 |
| Amy Bachrodt | Chief Financial Officer · Since at least Nov 4, 2026 |
| Chin Lee | Chief Medical Officer · Since at least Nov 4, 2026 |
| Darrin Lindhout | Vice President, Head of Biologics · Since at least Nov 4, 2026 |
| Jian Cao | Vice President, Head of CMC · Since at least Nov 4, 2026 |
| Karen Flick | General Counsel · Since at least Nov 4, 2026 |
| Laurent Fischer | Board Member · Since at least Nov 5, 2026 |
| Lynne Georgopoulos | Senior Vice President, Regulatory Affairs and Clinical Operations · Since at least Nov 4, 2026 |
| Nadia Tchao | Vice President, Head of Early Clinical Development · Since at least Nov 4, 2026 |
| Naomi Arana-Middendorf | Vice President, Program Management · Since at least Nov 4, 2026 |
| Sofia Touami | Chief Business Officer · Since at least Nov 4, 2026 |
| Steve Staben | Chief Scientific Officer · Since at least Nov 4, 2026 |
| William J. Rieflin | Chair, Lycia Therapeutics · Since at least Nov 5, 2026 |
| Winsome Chung | Senior Vice President, Finance · Since at least Nov 4, 2026 |